Samsung Biologics, the major biopharmaceutical unit of Korea’s Samsung Group, has become a global manufacturing hub for COVID-19 vaccines and drugs, joining forces with global drugmakers to curb the widespread pandemic.
All rights are reserved by the media that published this article.
Samsung Biologics, the major biopharmaceutical unit of Korea’s Samsung Group, has become a global manufacturing hub for COVID-19 vaccines and drugs, joining forces with global drugmakers to curb the widespread pandemic.
All rights are reserved by the media that published this article.